Medical Science Liaison, Autoantibody Pipeline - Western Us - Q410

.Johnson & Johnson is recruiting for a Pipeline Medical Science Liaison, Autoantibody TA based in the West Coast region of the US. At JNJ, we are working to create a world without disease. Transforming lives by finding new and better ways to prevent, intercept, treat and cure disease inspires us. We bring together the best minds and pursue the most promising science. At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech,we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.Jnj.Com/. The Medical Science Liaison (MSL) will establish and maintain relationships with leading researchers and clinicians, also known as key opinion leaders (KOLs). This individual will help serve as a scientific peer and resource, providing input about relevant data for external customers, and internal business partners. Key Responsibilities: Following all internal policies and functions as the scientific expert on current and future indications for JNJ's Autoantibody Pipeline assets. Execute on medical field initiatives with the objective of providing support to specialized and complex product launches in rare diseases, where education and translation of medical information into practical insights to support clinical decision-making are key. Build and maintain external relationships with recognized opinion leaders and/or investigators to foster collaboration throughout the lifecycle of the drug.Identify and address scientific needs of opinion leaders and investigators, while staying abreast of current scientific trends within the applicable rare diseases. Provide clinical support to opinion leaders treating a number of diseases with initial focus on benign hematologic and maternal-fetal autoantibody driven conditions. Expand JNJ's footprint by engaging with community physicians, on the clinical application of our existing and future products when appropriate. Respond to unsolicited requests for scientific information via 1:1 or group discussions, and, as needed, discuss disease state concepts and in-depth medical topics aligned with the medical affairs strategy. Collaborate with partners in Medical Affairs and in Clinical Research in support of Phase II to IV clinical trials, including site identification and selection.Actively participate in dissemination of final trial results. Provide support to investigator's requests for investigator-initiated studies according to company guidelines